Thermostable and Long-Circulating Albumin-Conjugated <i>Arthrobacter globiformis</i> Urate Oxidase

Urate oxidase derived from <i>Aspergillus flavus</i> has been investigated as a treatment for tumor lysis syndrome, hyperuricemia, and gout. However, its long-term use is limited owing to potential immunogenicity, low thermostability, and short circulation time in vivo. Recently, urate o...

Full description

Bibliographic Details
Main Authors: Byungseop Yang, Inchan Kwon
Format: Article
Language:English
Published: MDPI AG 2021-08-01
Series:Pharmaceutics
Subjects:
Online Access:https://www.mdpi.com/1999-4923/13/8/1298
_version_ 1827684397920288768
author Byungseop Yang
Inchan Kwon
author_facet Byungseop Yang
Inchan Kwon
author_sort Byungseop Yang
collection DOAJ
description Urate oxidase derived from <i>Aspergillus flavus</i> has been investigated as a treatment for tumor lysis syndrome, hyperuricemia, and gout. However, its long-term use is limited owing to potential immunogenicity, low thermostability, and short circulation time in vivo. Recently, urate oxidase isolated from <i>Arthrobacter globiformis</i> (AgUox) has been reported to be thermostable and less immunogenic than the <i>Aspergillus</i>-derived urate oxidase. Conjugation of human serum albumin (HSA) to therapeutic proteins has become a promising strategy to prolong circulation time in vivo. To develop a thermostable and long-circulating urate oxidase, we investigated the site-specific conjugation of HSA to AgUox based on site-specific incorporation of a clickable non-natural amino acid (frTet) and an inverse electron demand Diels–Alder reaction. We selected 14 sites for frTet incorporation using the ROSETTA design, a computational stability prediction program, among which AgUox containing frTet at position 196 (Ag12) exhibited enzymatic activity and thermostability comparable to those of wild-type AgUox. Furthermore, Ag12 exhibited a high HSA conjugation yield without compromising the enzymatic activity, generating well-defined HSA-conjugated AgUox (Ag12-HSA). In mice, the serum half-life of Ag12-HSA was approximately 29 h, which was roughly 17-fold longer than that of wild-type AgUox. Altogether, this novel formulated AgUox may hold enhanced therapeutic efficacy for several diseases.
first_indexed 2024-03-10T08:28:45Z
format Article
id doaj.art-ddb0151beb1b4b88a571fa2230f3cca3
institution Directory Open Access Journal
issn 1999-4923
language English
last_indexed 2024-03-10T08:28:45Z
publishDate 2021-08-01
publisher MDPI AG
record_format Article
series Pharmaceutics
spelling doaj.art-ddb0151beb1b4b88a571fa2230f3cca32023-11-22T09:15:43ZengMDPI AGPharmaceutics1999-49232021-08-01138129810.3390/pharmaceutics13081298Thermostable and Long-Circulating Albumin-Conjugated <i>Arthrobacter globiformis</i> Urate OxidaseByungseop Yang0Inchan Kwon1School of Materials Science and Engineering, Gwangju Institute of Science and Technology (GIST), Gwangju 61005, KoreaSchool of Materials Science and Engineering, Gwangju Institute of Science and Technology (GIST), Gwangju 61005, KoreaUrate oxidase derived from <i>Aspergillus flavus</i> has been investigated as a treatment for tumor lysis syndrome, hyperuricemia, and gout. However, its long-term use is limited owing to potential immunogenicity, low thermostability, and short circulation time in vivo. Recently, urate oxidase isolated from <i>Arthrobacter globiformis</i> (AgUox) has been reported to be thermostable and less immunogenic than the <i>Aspergillus</i>-derived urate oxidase. Conjugation of human serum albumin (HSA) to therapeutic proteins has become a promising strategy to prolong circulation time in vivo. To develop a thermostable and long-circulating urate oxidase, we investigated the site-specific conjugation of HSA to AgUox based on site-specific incorporation of a clickable non-natural amino acid (frTet) and an inverse electron demand Diels–Alder reaction. We selected 14 sites for frTet incorporation using the ROSETTA design, a computational stability prediction program, among which AgUox containing frTet at position 196 (Ag12) exhibited enzymatic activity and thermostability comparable to those of wild-type AgUox. Furthermore, Ag12 exhibited a high HSA conjugation yield without compromising the enzymatic activity, generating well-defined HSA-conjugated AgUox (Ag12-HSA). In mice, the serum half-life of Ag12-HSA was approximately 29 h, which was roughly 17-fold longer than that of wild-type AgUox. Altogether, this novel formulated AgUox may hold enhanced therapeutic efficacy for several diseases.https://www.mdpi.com/1999-4923/13/8/1298<i>Arthrobacter globiformis</i>gouthalf-life extensioninverse electron demand Diels-Alder reactionsite-specific albumin conjugationthermostability
spellingShingle Byungseop Yang
Inchan Kwon
Thermostable and Long-Circulating Albumin-Conjugated <i>Arthrobacter globiformis</i> Urate Oxidase
Pharmaceutics
<i>Arthrobacter globiformis</i>
gout
half-life extension
inverse electron demand Diels-Alder reaction
site-specific albumin conjugation
thermostability
title Thermostable and Long-Circulating Albumin-Conjugated <i>Arthrobacter globiformis</i> Urate Oxidase
title_full Thermostable and Long-Circulating Albumin-Conjugated <i>Arthrobacter globiformis</i> Urate Oxidase
title_fullStr Thermostable and Long-Circulating Albumin-Conjugated <i>Arthrobacter globiformis</i> Urate Oxidase
title_full_unstemmed Thermostable and Long-Circulating Albumin-Conjugated <i>Arthrobacter globiformis</i> Urate Oxidase
title_short Thermostable and Long-Circulating Albumin-Conjugated <i>Arthrobacter globiformis</i> Urate Oxidase
title_sort thermostable and long circulating albumin conjugated i arthrobacter globiformis i urate oxidase
topic <i>Arthrobacter globiformis</i>
gout
half-life extension
inverse electron demand Diels-Alder reaction
site-specific albumin conjugation
thermostability
url https://www.mdpi.com/1999-4923/13/8/1298
work_keys_str_mv AT byungseopyang thermostableandlongcirculatingalbuminconjugatediarthrobacterglobiformisiurateoxidase
AT inchankwon thermostableandlongcirculatingalbuminconjugatediarthrobacterglobiformisiurateoxidase